BUDESHINE F 200 CAP

BUDESHINE F 200 – Formoterol Fumarate and Budesonide Powder for Inhalation

Introduction

Respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) often require a dual-acting therapy that can provide both rapid symptom relief and long-term inflammation control.

BUDESHINE F 200 is a scientifically advanced inhalation therapy that combines Formoterol Fumarate (a long-acting bronchodilator) and Budesonide (a corticosteroid). This dual formulation is designed to target the root causes of breathing difficulties—airway inflammation and bronchoconstriction—providing patients with improved lung function, reduced symptoms, and better quality of life.

Composition

Each dose of BUDESHINE F 200 contains:

• Formoterol Fumarate – A long-acting β2-adrenergic agonist (LABA)

• Budesonide 200 mcg – An inhaled corticosteroid (ICS)

Mechanism of Action

Formoterol Fumarate

• Acts as a long-acting bronchodilator.

• Stimulates β2-receptors in the airway smooth muscle, leading to relaxation and widening of bronchial passages.

• Provides rapid onset (within minutes) and sustained action for up to 12 hours, ensuring long-lasting relief from breathlessness and wheezing.

Budesonide

• A potent corticosteroid with powerful anti-inflammatory properties.

• Reduces swelling, irritation, and mucus production in the airways.

• Helps prevent asthma attacks and COPD exacerbations when used regularly.

 Together, this combination ensures symptom relief, prevention of flare-ups, and long-term disease control.

Therapeutic Indications

BUDESHINE F 200 is prescribed for:

• Asthma – maintenance therapy for patients requiring both a bronchodilator and corticosteroid.

• Chronic Obstructive Pulmonary Disease (COPD) – including chronic bronchitis and emphysema.

• Prevention of Exercise-Induced Bronchospasm (when used as maintenance therapy).

Dosage and Administration

• Typical Adult Dose: 1 inhalation twice daily, or as directed by a physician.

• Route: Oral inhalation using a dry powder inhaler device.

• Important: Not meant for acute asthma attacks—patients should keep a short-acting bronchodilator (rescue inhaler) for emergencies.

Key Benefits of BUDESHINE F 200

Dual Action Therapy: Combines bronchodilation and anti-inflammatory control.
Rapid Relief + Long-Term Protection: Works within minutes and lasts up to 12 hours.
Improved Lung Function: Enhances airflow and reduces breathing difficulties.
Reduces Exacerbations: Prevents frequent asthma and COPD flare-ups.
Better Patient Compliance: Convenient combination in a single inhalation.

Possible Side Effects

Like all inhaled therapies, BUDESHINE F 200 may cause some mild side effects, including:

• Throat irritation or cough

• Hoarseness of voice

• Oral thrush (fungal infection)

• Headache or dizziness

• Rarely, palpitations or tremors

Tip: Rinsing the mouth after each inhalation reduces the risk of oral thrush and throat irritation.

Precautions & Warnings

• Not for emergency relief of acute asthma symptoms.

• Use cautiously in patients with heart disease, hypertension, diabetes, or thyroid disorders.

• Monitor growth in children on long-term therapy.

• Pregnant or breastfeeding women should use only under medical supervision.

• Regular medical follow-up is essential for patients on chronic therapy.

Storage

• Store in a cool, dry place, away from direct sunlight.

• Keep the inhaler tightly closed after use.

• Keep out of reach of children.